Supporting progress & translation of gene & cell therapies
The aim of the British Society for Gene and Cell Therapy is to support scientific progress and promote ethical and efficient translation of gene- and cell-based technologies from the laboratory into the clinic.
Introducing the Current and New Members of the BSGCT Board
We are delighted to introduce the current and newly appointed members of the BSGCT Board. We are grateful to our existing Board members for their continued commitment and warmly welcome the new members joining us as we work together to advance the field of gene and cell therapy.
The British Society for Gene and Cell Therapy (BSGCT) serves as a collaborative platform to advance Gene and Cell Therapy (GCT) in the UK.
We proactively foster cooperation among stakeholders, including the public, patients, scientists, companies, government, and media to support the optimal development of GCT technologies and therapies.
Our charity is managed by volunteer members via an Elected-Board and Sub-Committees. We rely on the crucial support of our sponsors and members and invite you to get involved.
BSGCT News and Opportunities
Poster and Oral Presentation Awards BSGCT 2026
Poster Awards BSGCT 2026 sponsored Han Zhang The development of a PEG-bPEI nanogel-based delivery system for nucleic acids sponsored Melissa…
Scientific Writing Competition 2026
WINNER Jyoti Yadav – Teaching Our Own Soldiers to Fight Smarter: Engineering T Cells to Conquer Solid Tumours RUNNERS UP…
BSGCT Board elections update
Dear BSGCT Members, As we approach our upcoming Annual General Meeting (AGM), we would like to provide an update regarding…